NLRP3 and depressive symptom measurement: More importantly, the present study discovered that KF1 could reverse the pathological changes in the LPS-induced depression model by activating PPAR-γ/CX3CR1/Nrf2 signaling, and suppressing NF-κB/NLRP3 signaling pathways.